These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2751387)

  • 1. [Electroflotation packing of mycelial wastes].
    Nikolaev VB; Karpukhin VF; Zav'ialova EV; Faingol'd ZL
    Antibiot Khimioter; 1989 Apr; 34(4):289-91. PubMed ID: 2751387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Utilization of mycelial waste of antibiotic production in the technology of kilned construction materials].
    Karpukhin VF; Krymskiĭ MV; Ivanov IA; Makridin NI; Kalashnikov VI
    Antibiot Med Biotekhnol; 1985 Jan; 30(1):32-5. PubMed ID: 3994341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Purification of waste water from the antibiotic-producing industry using synthetic sorbents].
    Generalov SD; Abramov AV; Karpukhin VF; Kliueva LM
    Antibiot Khimioter; 1991 Dec; 36(12):22-3. PubMed ID: 1814269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The possibility for obtaining sorbents from the mycelial wastes of antibiotic production].
    Iakubova AR; Lagunov VM; Faĭngol'd ZL
    Antibiot Khimioter; 1995 May; 40(5):35-7. PubMed ID: 8534179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of carbohydrates on possible utilization of wastes from antibiotic-manufacturing plants in the construction industry].
    Tarakanov OV; Kalashnikov VI; Krymskiĭ MV; Karpukhin VF
    Antibiot Khimioter; 1989 Aug; 34(8):606-9. PubMed ID: 2589901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The treatment of wastes from antibiotic manufacture by using pyrolusite].
    Faĭngol'd ZL; Zav'ialova EV; Karpukhin VF; Agafonova VA
    Antibiot Med Biotekhnol; 1987 Nov; 32(11):833-7. PubMed ID: 3439788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Certification Scheme on the Quality of Pharmaceutical Products moving in International Commerce.
    WHO Chron; 1977 Dec; 31(12):suppl 1-19. PubMed ID: 602166
    [No Abstract]   [Full Text] [Related]  

  • 8. Guidance for temperature-controlled medicinal products: maintaining the quality of temperature-sensitive medicinal products through the transportation environment.
    Parenteral Drug Association
    PDA J Pharm Sci Technol; 2007; 61(2 Suppl TR 39):2-19. PubMed ID: 17953229
    [No Abstract]   [Full Text] [Related]  

  • 9. [Means of accelerating scientific and technological progress in antibiotic production].
    Padalkin VP
    Antibiot Khimioter; 1988 Jun; 33(6):403-8. PubMed ID: 3421762
    [No Abstract]   [Full Text] [Related]  

  • 10. [The possibility of using the mycelial wastes from the production of antifungal antibiotics as additives to lubricating oils].
    Belakhov VV; Shenin IuD
    Antibiot Khimioter; 1997; 42(5):35-7. PubMed ID: 9254586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sevoflurane: are there differences in products?
    Baker MT
    Anesth Analg; 2007 Jun; 104(6):1447-51, table of contents. PubMed ID: 17513639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The historical delivery of antibiotics from microbial natural products--can history repeat?
    Peláez F
    Biochem Pharmacol; 2006 Mar; 71(7):981-90. PubMed ID: 16290171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploitation of biological wastes for the production of value-added products under solid-state fermentation conditions.
    Rodríguez Couto S
    Biotechnol J; 2008 Jul; 3(7):859-70. PubMed ID: 18543242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Assessment Approach to Microbiological Controls of Cell Therapies.
    Cundell T; Drummond S; Ford I; Reber D; Singer D;
    PDA J Pharm Sci Technol; 2020; 74(2):229-248. PubMed ID: 31941793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative evaluation of mathematical models of the process for the biological treatment of the wastes from antibiotic manufacture].
    Vavilin VA; Vasil'ev VB; Abramov AV; Karpukhin VF; Iakubova AR
    Antibiot Med Biotekhnol; 1987 Mar; 32(3):214-8. PubMed ID: 3579250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fermentative hydrolysate of mycelial waste of aminoglycoside antibiotics production as component of culture media used in biosynthesis of tobramycin].
    Cherkashina NV; Litusov NV; Mikhaĭlov VA; Vasil'ev PG; Rogozhin AZ; Makhortov VL; Bunakov IuP; Ustinova NB; Andrus EA
    Antibiot Khimioter; 2003; 48(10):3-6. PubMed ID: 15004972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of methods of drying mycelial waste].
    Iakbova AR; Solov'eva TA; Zhiganova EM; Faĭgol'd ZL; Sivacheva OV
    Antibiot Khimioter; 1995 Jul; 40(7):15-21. PubMed ID: 8645053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short communication: a study on the packaging information of essential drug products used at Union and Thana health complex level in Bangladesh.
    Amran S; Ahmed M; Shaheen SM; Morshed SN; Khandakar J; Rahman M; Rahman M; Hossain A
    Pak J Pharm Sci; 2007 Oct; 20(4):327-32. PubMed ID: 17604258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Universal appliance for pressing metal caps].
    Meerkop GE
    Farmatsiia; 1979; 28(5):39-42. PubMed ID: 488399
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk analysis in the manufacture of veterinary biologicals.
    Moreau Y
    Rev Sci Tech; 1995 Dec; 14(4):937-50. PubMed ID: 8639962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.